Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07CPM
|
|||
| Drug Name |
GP2013
|
|||
| Indication | Chronic lymphocytic leukaemia [ICD-11: 2A82.0; ICD-10: C83.0, C91.1] | Phase 3 | [1] | |
| Diffuse large B-cell lymphoma [ICD-11: 2A81; ICD-10: C83.3; ICD-9: 200] | Phase 3 | [1] | ||
| Follicular lymphoma [ICD-11: 2A80; ICD-9: 202] | Phase 3 | [2] | ||
| Rheumatoid arthritis [ICD-11: FA20] | Phase 2 | [3] | ||
| Company |
SandozHolzkirchen, Germany
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | ClinicalTrials.gov (NCT01419665) GP2013 in the Treatment of Patients With Previously Untreated, Advanced Stage Follicular Lymphoma (ASSIST_FL) (ASSIST_FL). U.S. National Institutes of Health. | |||
| REF 3 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.